ENVALITH
日本パーカライジング株式会社 logo

Nihon Parkerizing Co., Ltd.

4095・Prime Market・Chemicals

Official website
日本パーカライジング株式会社 logo
Nihon Parkerizing Co., Ltd.4095

Business

Nippon Paint Surf Chemicals (Nihon Parkerizing) is a specialized surface treatment manufacturer founded in 1928, built on three core businesses: manufacturing and sale of surface treatment agents for cleaning, rust prevention, coating undercoats, lubrication, and design purposes on metal materials (Chemicals Business); manufacturing and sale of pretreatment and coating equipment, etc. (Equipment Business); and processing services such as rust prevention, heat treatment, and plating (Processing Business). The group, including 42 domestic consolidated subsidiaries, has a wide network of locations across Asia (China, India, Southeast Asia) as well as Europe and the Americas. Its main customers are in the automotive and steel industries, and consolidated net sales for FY2026 (ending March 2026) of ¥138,155 million marked a record high since the company began quarterly disclosures.

Business Model

In the Chemicals Business, the company provides technical support in addition to manufacturing and selling surface treatment agents, securing stable revenue by becoming continuously embedded in customers' production lines. In the Equipment Business, it provides pretreatment and coating equipment linked to its chemicals, while in the Processing Business, it provides added value through contract processing services utilizing its proprietary technology. Through the vertical integration of these three businesses, the company covers customers' entire manufacturing processes and builds relationships with high switching costs.

Company Strengths

Since its founding in 1928, the company has accumulated core technologies including chemical conversion treatment, functional coatings, and process technology. In April 2025, it opened a new comprehensive technology research institute, the 'Parker Innovation Center,' and newly established a Core Technology Research Department and an Advanced Technology Research Department. In FY2026 (ending March 2026), R&D expenses of ¥2,754 million were invested, driving technology expansion into new fields such as decarbonization, medical, and electronics.

The company has pursued aggressive global expansion starting with Taiwan (1965), and now holds numerous locations across China, India, Southeast Asia, Europe, and the Americas. In the Chemicals Business alone, 20 overseas companies participate, and in the Equipment Business, local subsidiaries have been established in India, China, Thailand, Indonesia, and elsewhere. Sales in the Asia region grew 8.0% year-on-year in FY2026 (ending March 2026), achieving high growth, and the company has built a regional management system rooted in local operations.

As of the end of FY2026 (ending March 2026), the equity ratio stood at 73.9% (up 0.9 percentage points year-on-year), and the interest coverage ratio was an extremely high 2,984.0 times, maintaining an extremely sound financial condition. Interest-bearing debt is minimal, and capital expenditure, share buybacks, and dividends are, in principle, funded by internal resources. The company secured a cash and cash equivalents balance of ¥53,849 million at period-end, giving it the financial capacity to simultaneously pursue growth investments and shareholder returns.

ENVALITH's Perspective

Net sales of ¥138,155 million for FY2026 (ending March 2026) marked a new record high since FY2004 (ending March 2004), while the operating margin continued to decline to 10.7% (from 11.3% in the previous fiscal year). Raw material prices remaining at elevated levels, along with rising labor costs and depreciation expenses, are squeezing profits in the Chemicals Business and Processing Business, resulting in a persistent structure where revenue growth does not readily translate into profit growth. The forecast for FY2027 (ending March 2027) calls for a slight increase in operating profit to ¥15,000 million (up 1.3% year on year), but net sales are expected to decline to ¥134,000 million (down 3.0% year on year), making the feasibility of margin improvement a key focus.

In the Processing Business, the Europe and U.S. region posted net sales of ¥9,827 million (down 2.8% year on year) and swung to an operating loss of ¥569 million (a sharp deterioration from a profit of ¥74 million in the previous fiscal year). Sluggish sales by Japanese automakers also weighed on results in Thailand, China, and elsewhere, causing overall operating profit in the Processing Business to decline 6.8% year on year. An impairment loss of ¥805 million (in the Processing Business segment) was also recorded, reflecting continued restructuring costs. Attention is focused on the timing and scale of synergy effects from the integration of the Processing Business into Parker Processing Corporation in April 2026.

In FY2026 (ending March 2026), the company conducted share buybacks totaling ¥8,640 million, bringing treasury shares outstanding at fiscal year-end to 24,351,467 shares (18.4% of shares issued). Due to the decrease in the average number of shares outstanding during the period, earnings per share increased to ¥117.16 (from ¥112.20 in the previous fiscal year), despite profit attributable to owners of parent declining 1.3% year on year to ¥12,940 million. Earnings per share for FY2027 (ending March 2027) is forecast to increase substantially to ¥139.65 (up 8.2% year on year), indicating that continued share buybacks are directly contributing to enhancing shareholder value.

Growth Strategy

Under the 5th Medium-Term Management Plan 'Challenge for Change,' the company aims for sustainable growth through overseas expansion, DX, integration of the Processing Business, and utilization of the new research institute.

Under the slogan 'Challenge for Change!,' the company is focusing on deepening existing businesses, expanding overseas operations, and cultivating new business fields. It aims to achieve both improved capital efficiency and sustainable growth, targeting ROE of 8% or higher. For FY2027 (ending March 2027), the company plans net sales of ¥134,000 million and operating profit of ¥15,000 million.

Effective April 1, 2026, the company integrated its Processing Business Division with Parker Kako Co., Ltd. through a simplified absorption-type company split, establishing Parker Processing Co., Ltd. This aims to maximize group synergies and improve productivity by combining the technologies and know-how of both companies.

Centered at the new comprehensive research institute, which opened in April 2025, the company is advancing the development of surface modification technologies that contribute to a decarbonized society. Research and development expenses were significantly expanded to ¥2,754 million (up 25.9% from ¥2,185 million in the previous fiscal year), strengthening both the development of core technologies and forward-looking R&D.

The company continues to expand sales of the Equipment Business in India, China, and other markets (Asia Equipment Business sales up 40.6% year on year), while also strengthening the Asian expansion of the Chemicals Business and Processing Business. Total sales in Asia reached ¥48,892 million (up 7.2% year on year), and the company continues to focus on this high-growth market.

In FY2026 (ending March 2026), the company acquired ¥8,640 million of treasury shares, and has also resolved to continue share buybacks in FY2027 (ending March 2027). While maintaining an annual dividend of ¥50 per share (forecast payout ratio of 35.8%), the company is simultaneously pursuing EPS improvement through share buybacks and improved capital efficiency (targeting ROE of 8% or higher).

Last updated: July 19, 2026